Cardiologists at Newark Beth Israel Medical Center, an RWJBarnabas Health facility, revealed a major innovation Sept. 22 — a minimally invasive procedure that may eliminate or lower the need for surgery for congenital heart disease patients.
The center said, this summer, it was the first in New Jersey to implant the Sapien 3 Transcatheter Pulmonary Valve System with Alterra Adaptive Prestent on a patient with the condition. The system is used to treat patients with leaky or narrowed pulmonary valves, which is a common condition in these instances.
What’s more, this system allows younger patients – who traditionally were ineligible for implantations because of the size and structure of their heart valves – to receive a pulmonary valve without undergoing open heart surgery, the center said.
Click here to see which hospitals recently earned recognition for cardiac care.
Dr. Rajiv Verma, pediatric and adult congenital heart disease specialist, interventional cardiologist, and director of the Children’s Heart Center at Newark Beth Israel, performed the procedure.
“The availability of this system means that patients who in the past would automatically need surgery no longer need to endure invasive open-heart surgery to treat their congenital heart disease,” Verma said in a statement. “Not only does the new system allow for quicker recovery, patients are typically discharged in a day and can resume regular activities within a week, but it can help keep young patients potentially free of cardiac surgery for an additional 10-20 years.”
Dr. Marc Cohen, chair of the Department of Medicine at Newark Beth Israel, added, “[W]e are proud to be able to bring a treatment to patients that can significantly reduce the number of surgeries and procedures during their lifetimes and help improve their overall quality of life.”